Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kesko's share-based commitment and incentive plans for 2020-2023

Kesko Corporation's Board of Directors has decided that the target group for the 2020–2021 performance period of Kesko’s share-based commitment and incentive plan PSP (Performance Share Plan) will comprise approximately 50 key members of Kesko’s management. The Board of Directors has also decided to establish a new share-based commitment and incentive plan, the Key Personnel Share Plan (KPSP) for other Kesko key persons selected separately. The target group for the KPSP for the 2020 performance period comprises approximately 100 persons. The Board has also confirmed the criteria for 2020 for

The bright future of suburbs

YIT Corporation News February 5, 2020, at 9:30 a.m.The word “suburb” may evoke strong preconceptions in people. Studies have shown that the preconceptions of suburbs are bleaker among those who don’t actually live in them. Perhaps it has not caught their attention that many traditional suburbs are now the subject of active development. The term suburb is rarely used in adverts for apartments because of the negative connotations it carries. Nevertheless, suburbs are part of everyday reality for many people. It is estimated that some 1.5 million Finns live in suburban areas. The term

NOTE’s Year-end Report 2019

Financial performance October–December• Sales increased by 22% to SEK 483 (397) million. Excluding acquisitions, growth was 20%.• Operating profit was up by 27% to SEK 35 (28) million.• The operating margin widened by 0.3 percentage points to 7.4% (7.1%).• Profit after financial items increased by 24% to SEK 33 (27) million.• Profit after tax increased to SEK 26 (24) million, corresponding to SEK 0.90 (0.83) per share.• Cash flow after investments including acquisitions amounted to SEK 96 (-81) million, or SEK 3.32 (-2.80) per share.Financial performance January–December•

Successful combination of Alpha1H with chemotherapy

Alpha1H shows significant promise as a new and effective cancer drug with low toxicity in a clinical bladder cancer study. Now, a new, pre-clinical discovery shows that Alpha1H also improves the therapeutic efficacy of other cancer drugs. By combining Alpha1H with low doses of chemotherapeutic agents, an increase in treatment efficacy was observed. The findings suggest that that in addition to acting as a cancer drug on its own, Alpha1H may be used in combination with chemotherapy, to further improve therapeutic efficacy.This combination effect was demonstrated in a bladder cancer model in

Veoneer Selected to Supply System Based on Next Generation Vision and Radar System

Stockholm, Sweden, February 5, 2020: Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), the world’s largest pure-play company focused on Advanced Driving Assistance Systems and Automated Driving, and its software joint venture Zenuity, have been selected by a global, Asia-based, automaker to supply an active safety system based on its next generation Mono Vision and Radar System. This is the eighth customer for Veoneer’s in-house developed vision system.Veoneer’s scalable system has been developed to meet Euro NCAP 5-star safety rating as well as providing several driver assistance features such

Danske Hypotek AB: Year-end report 2019

Year in briefJanuary – December 2019 (the comparison in brackets refers to 2018)· Operating profit was SEK 965 million (717 million) · Net interest income amounted to SEK 1 050 million (825 million) · Costs comprised SEK 101 million (61 million) · Credit losses remained low and amounted to SEK 47 million (SEK -2 million) · Return on equity was 16.9 % (18.4 %) · The CET1 capital ratio was 16.7% (16.1%) · Danske Hypotek’s covered bonds have the highest credit rating (AAA) from Standard & Poor’s Read the full year-end report at https://danskehypotek.se/financial-

Shareholders' proposals to the Annual General Meeting for the remuneration of Kesko's Board of Directors

Kesko Corporation's shareholders jointly holding 15% of the votes attached to the Company’s shares have made a proposal to the Annual General Meeting to be held on 30 March 2020 regarding the remuneration of Board members and the reimbursement of their expenses.Proposal for the remuneration of Board members and the reimbursement of their expenses Kesko Corporation's shareholders jointly holding 15% of the votes attached to the Company’s shares have proposed that the fees for Kesko Corporation’s Board members remain at their current level. The proposal for remuneration and the

Annual report 2019 – Delivered best-in-class results and record high order intake

Vestas Wind Systems A/S, Aarhus, 5 February 2020Company announcement No. 01/2020   Annual report 2019 – Delivered best-in-class results and record high order intake Summary: For full year 2019, revenue amounted to EUR 12.1bn, the EBIT margin before special items was 8.3 percent, and total investments* were EUR 729m, all in line with the expectations. Compared to 2018, revenue and earnings increased while free cash flow decreased. Order intake increased in 2019 compared to 2018, and the value of the combined order backlog increased to EUR 34bn.   The wind turbine order intake

Interim Report Q3 1 April - 31 December 2019

Third quarter (1 October - 31 December 2019) · Net sales increased by 12 percent and amounted to SEK 2,846 million (2,551). · Operating profit before amortisation of intangible non-current assets (EBITA) decreased by 4 percent and amounted to SEK 236 million (246) corresponding to an EBITA margin of 8.3 percent (9.7). · Operating profit decreased by 7 percent and amounted to SEK 188 million (203) corresponding to an operating margin of 6.6 percent (7.9). · Profit after tax decreased by 9 percent and amounted to SEK 142 million (156) and earnings per share before dilution

Consort Medical becomes part of the Recipharm Group

Recipharm announced on 4 February 2020 that the offer to acquire Consort Medical plc (“Consort”) (the “Offer”) had become unconditional in all respects and will remain open for acceptances for a further 14 days, until 18 February 2020.  For more information on the Offer, Recipharm refers to the press release published on 4 February 2020. As a result of the Offer being declared wholly unconditional, Consort’s 2,000 employees and 10 facilities across the UK, Italy and Germany will become part of the Recipharm Group. Commenting on the announcement, Thomas Eldered, CEO at Recipharm said: “

KESKO BOARD'S PROPOSALS TO THE ANNUAL GENERAL MEETING

Kesko Corporation's Board of Directors has decided to propose to the Annual General Meeting convened for 30 March 2020 that a dividend of €2.52 per share be paid for the year 2019, that a resolution be made on a share issue without payment (share split) and on an amendment to section 3 of the Company’s Articles of Association, that the Board be authorised to decide on the issuance of shares, that a Shareholders’ Nomination Board be established, and that the Board be authorised to decide on donations for charitable purposes. The Board proposes that the firm of authorised public accountants

SimCorp A/S – New Share buyback program

Company Announcement no. 2/2020 SimCorp A/S (“SimCorp”) has today initiated a share buyback program for up to EUR 10.0m, to be executed during the period from February 5, 2020 to July 31, 2020. The buyback program is being launched in accordance with the authorization granted by the shareholders at the Annual General Meeting on March 27, 2019 to repurchase up to 10% of the SimCorp’s share capital in the period until the next annual general meeting. The buyback program will be structured and carried out in compliance with the provisions of Regulation No. 596/2014 of the European

Outokumpu initiates a strategic review of business area Long Products

Outokumpu OyjPress releaseFebruary 5, 2020 at 9.05 am EETOutokumpu initiates a strategic review of business area Long Products Outokumpu has initiated a strategic review of business area Long Products as part of its process to determine optimal long-term business mix for the company. During the review, Outokumpu will investigate multiple options regarding the business area’s future including opportunities for consolidation within the stainless long products markets. The strategic review is expected to be finalized during 2020. In 2019, business area Long Products’ net sales

H&M’s nomination committee proposes that Karl-Johan Persson is elected as the new chairman of the board of H & M Hennes & Mauritz AB at the annual general meeting on 7 May 2020

As communicated last week, Stefan Persson has announced that he will not stand for re-election as chairman of H&M at this spring’s annual general meeting. The nomination committee has unanimously decided to propose Karl-Johan Persson as new chairman of the board of H&M at the annual general meeting on 7 May 2020. In addition, the nomination committee will propose the re-election of all the current AGM-elected board members apart from Stefan Persson. It is therefore proposed that Stina Bergfors, Anders Dahlvig, Danica Kragic Jensfelt, Lena Patriksson Keller, Christian Sievert, Erica Wiking

Hexagon Year-End Report 1 January - 31 December 2019

Fourth quarter 2019- Net sales increased by 2 per cent to 1,058.9 MEUR (1,043.0). Using fixed exchange rates and a comparable group structure (organic growth), net sales decreased by -2 per cent- Operating earnings (EBIT1) increased by 2 per cent to 277.0 MEUR (270.7)- Earnings before taxes, excluding non-recurring items, amounted to 271.1 MEUR (265.4)- Net earnings, excluding non-recurring items, amounted to 222.3 MEUR (217.6)- Earnings per share, excluding non-recurring items, amounted to 0.60 EUR (0.60)- Operating cash flow, excluding non-recurring items, decreased to 234.4

Year-end Report January - December 2019

Period October - DecemberPeriod January - DecemberOctober – December in brief · Net sales rose by 22 percent to SEK 12,830 (10,537) thousand. · Gross profit improved by 1,109 thousand to SEK 12,065 (10,956) thousand. · Operating profit before depreciation and amortization (EBITDA) totaled SEK 492 (2,954) thousand. · Operating earnings fell SEK 2,434 to a loss of SEK 522 (profit: 1,912) thousand. · Comprehensive income for the period declined by SEK 2,180 thousand to a loss of SEK 895 (profit: 1,285) thousand. · Comprehensive income per share, basic and diluted, totaled

Year-end report 2019 Bactiguard Holding AB

A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that our growth strategy works.Fourth quarter (October-December 2019) · Revenues amounted to SEK 61.6 (42.1) million, an increase of 46% mainly driven by higher BIP sales but also higher license revenues from BD.  · BIP sales amounted to SEK 25.3 (14.4) million. The increase of 75% is essentially a result of positive development in China

Year-end report 2019

THE SUBSIDIARY QLIRO AB TO BE LISTED, CDON BEING PREPARED FOR DISTRIBUTION TO OWNERS AND NELLY IMPLEMENTS ACTION PLAN FOURTH QUARTER[1] · Net sales amounted to SEK 919.2 (1,047.0) million · The subsidiary Qliro AB (previously called Qliro Financial Services) increased its loan book by 39 percent and total operating income by 8 percent · CDON increased its external merchant sales by 75 percent · Nelly’s net sales decreased by 1 percent · The gross margin increased to 22.7 (23.6) percent · Operating profit before depreciation and amortization amounted to SEK -18.5 (

Year-end Report January-December 2019

A QUARTER PERVADED BY TRANSACTIONS AND STRONG ORDER BOOKINGSOctober–December 2019 ·Order bookings amounted to SEK 2,969 million (1,000) ·Income amounted to SEK 2,253 million (1,991) ·The operating loss amounted to SEK 97 million (profit 509) ·Cash flow from operating activities amounted to SEK 83 million (264). Cash flow was affected adversely by investments of SEK 157 million in the production of tenant-owner apartments and the Karlastaden project ·The loss for the period amounted to SEK 63 million (profit 572) ·The final settlement of the

Sedana Medical establishes sales organization in Benelux

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has set up its own direct sales organization in Benelux, in line with the strategy of being represented in several European markets in order to have well-established networks and reference ICUs in Europe when IsoConDa is approved. The establishment in Benelux means that Sedana Medical now has its own representation in ten European countries.“We are proud that we can now start building market presence for inhaled sedation also in Belgium and the Netherlands. This is fully in line with our strategy to

Kesko's financial statements release for the period 1 Jan. to 31 Dec. 2019: Growth strategy yields record result

FINANCIAL PERFORMANCE IN BRIEF, CONTINUING OPERATIONS:                                     · Group net sales in January-December totalled €10,720.3 million (€10,382.8 million), an increase of 1.4% in comparable terms, reported net sales grew by 3.3% · Comparable operating profit totalled €461.6 million (€428.5 million) · Operating profit totalled €447.8 million (€404.3 million) · Comparable return on capital employed was 9.6% (9.8%) · Comparable profit before tax totalled €370.7 million (€325.2 million) · Comparable earnings per share totalled €2.97 (€2.45) · The Board

Outokumpu Financial Statements Release 2019 – Significant reduction of net debt to EUR 1,155 million

Outokumpu OyjFinancial statements releaseFebruary 5, 2020 at 9.00 am EETOutokumpu Financial Statements Release 2019 – Significant reduction of net debt to EUR 1,155 million Highlights in the fourth quarter of 2019 · Stainless steel deliveries were 458,000 tonnes (534,000 tonnes)1. · Adjusted EBITDA was EUR 73 million (EUR 89 million). · EBITDA was EUR 90 million (EUR 92 million). · Operating cash flow was EUR 143 million (EUR 43 million). · Net debt was EUR 1,155 million (September 30, 2019: EUR 1,336 million). · Gearing was 45.1% (September 30, 2019: 51.4%).

Loomis full-year report January – December 2019

October – December 2019Revenue for the fourth quarter amounted to SEK 5,342 million (4,956). Real growth was 5 percent (8) and organic growth was 1 percent (3). Loomis operating income (EBITA)[1)] amounted to SEK 693 million (593) and the operating margin was 13.0 percent (12.0). Income before taxes amounted to SEK 552 million (515) and income after taxes was SEK 407 million (387). Earnings per share before and after dilution amounted to SEK 5.42 (5.14). Cash flow from operating activities[2)] amounted to SEK 325 million (856), equivalent to 48 percent (144) of operating

There are no items matching the current filter
There are no more items matching the current filter
Back to top